Cargando…

Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE

OBJECTIVE: To investigate the characteristics of coagulation indicators, such as C-reactive protein (CRP), antithrombin (AT), and fibrinogen (FB) in patients with pulmonary thromboembolism (PTE) and their relationship with PTE. METHODS: The clinical characteristics, CRP, AT, FB, plasma D-dimer (D-D)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Yan, Tan, Yong, Yan, Min, Cheng, Zhen, Pan, Xiang-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558423/
https://www.ncbi.nlm.nih.gov/pubmed/34737613
http://dx.doi.org/10.2147/IJGM.S333747
_version_ 1784592557909475328
author Wu, Yu-Yan
Tan, Yong
Yan, Min
Cheng, Zhen
Pan, Xiang-Tao
author_facet Wu, Yu-Yan
Tan, Yong
Yan, Min
Cheng, Zhen
Pan, Xiang-Tao
author_sort Wu, Yu-Yan
collection PubMed
description OBJECTIVE: To investigate the characteristics of coagulation indicators, such as C-reactive protein (CRP), antithrombin (AT), and fibrinogen (FB) in patients with pulmonary thromboembolism (PTE) and their relationship with PTE. METHODS: The clinical characteristics, CRP, AT, FB, plasma D-dimer (D-D) and platelet (PLT) counts, and blood coagulation indicators of 433 patients with PTE diagnosed by computed tomographic pulmonary angiography (CTPA) were comprehensively analyzed, and the relevant clinical significance was discussed. RESULTS: The total incidence of PTE was 1.60% (433/270,983 cases), and the age group with the highest incidence was over 60 years old. D-D increased in 412 (95.2%) patients. PLT was normal in 331 (76.4%) cases, but decreased in 53 (12.3%) cases and increased in 49 (11.3%) cases. CRP increased in 76.0% (288/379 cases) and was normal in 24.0% (91/379 cases). AT decreased in 109 (25.2%) cases and FB increased in 102 (23.6%) cases. There were no significant changes in other coagulation indexes. CRP was positively correlated with PLT and FB (r = 0.1026, t = 2.0118, P < 0.05, and r = 0.5360, t = 12.2963, P < 0.01, respectively). CRP was negatively correlated with AT (r = –0.2005, t = 4.0100, P < 0.01). CONCLUSION: The incidence of PTE was higher in hospitalized patients. Most patients with PTE have increased CRP and FB and decreased AT, and these levels may be related to the occurrence of PTE.
format Online
Article
Text
id pubmed-8558423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85584232021-11-03 Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE Wu, Yu-Yan Tan, Yong Yan, Min Cheng, Zhen Pan, Xiang-Tao Int J Gen Med Original Research OBJECTIVE: To investigate the characteristics of coagulation indicators, such as C-reactive protein (CRP), antithrombin (AT), and fibrinogen (FB) in patients with pulmonary thromboembolism (PTE) and their relationship with PTE. METHODS: The clinical characteristics, CRP, AT, FB, plasma D-dimer (D-D) and platelet (PLT) counts, and blood coagulation indicators of 433 patients with PTE diagnosed by computed tomographic pulmonary angiography (CTPA) were comprehensively analyzed, and the relevant clinical significance was discussed. RESULTS: The total incidence of PTE was 1.60% (433/270,983 cases), and the age group with the highest incidence was over 60 years old. D-D increased in 412 (95.2%) patients. PLT was normal in 331 (76.4%) cases, but decreased in 53 (12.3%) cases and increased in 49 (11.3%) cases. CRP increased in 76.0% (288/379 cases) and was normal in 24.0% (91/379 cases). AT decreased in 109 (25.2%) cases and FB increased in 102 (23.6%) cases. There were no significant changes in other coagulation indexes. CRP was positively correlated with PLT and FB (r = 0.1026, t = 2.0118, P < 0.05, and r = 0.5360, t = 12.2963, P < 0.01, respectively). CRP was negatively correlated with AT (r = –0.2005, t = 4.0100, P < 0.01). CONCLUSION: The incidence of PTE was higher in hospitalized patients. Most patients with PTE have increased CRP and FB and decreased AT, and these levels may be related to the occurrence of PTE. Dove 2021-10-27 /pmc/articles/PMC8558423/ /pubmed/34737613 http://dx.doi.org/10.2147/IJGM.S333747 Text en © 2021 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Yu-Yan
Tan, Yong
Yan, Min
Cheng, Zhen
Pan, Xiang-Tao
Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title_full Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title_fullStr Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title_full_unstemmed Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title_short Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
title_sort analysis of crp, antithrombin, fibrinogen, and hematological changes in 433 patients with pte
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558423/
https://www.ncbi.nlm.nih.gov/pubmed/34737613
http://dx.doi.org/10.2147/IJGM.S333747
work_keys_str_mv AT wuyuyan analysisofcrpantithrombinfibrinogenandhematologicalchangesin433patientswithpte
AT tanyong analysisofcrpantithrombinfibrinogenandhematologicalchangesin433patientswithpte
AT yanmin analysisofcrpantithrombinfibrinogenandhematologicalchangesin433patientswithpte
AT chengzhen analysisofcrpantithrombinfibrinogenandhematologicalchangesin433patientswithpte
AT panxiangtao analysisofcrpantithrombinfibrinogenandhematologicalchangesin433patientswithpte